To examine whether HA-coated nanoparticle treatment selectively increases cytotoxicity in breast cancer cells via activated CD44, an MTT (3-(4, 5-dimethylthiazolyl-2)-2, 5-diphenyltetrazolium bromide) assay was performed to assess in vitro cytotoxicity. The gene discussed is CD44; the disease is breast carcinoma.